A Prediction Model for the 40-Year Risk of Knee Osteoarthritis in Adolescent Men.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
04 2019
Historique:
received: 08 02 2018
accepted: 26 06 2018
pubmed: 29 6 2018
medline: 3 1 2020
entrez: 29 6 2018
Statut: ppublish

Résumé

To simplify the previously published Nottingham 12-year risk prediction model for knee osteoarthritis (OA) and examine whether it can be used to predict the 40-year risk of knee OA in young men. Our cohort included 40,118 men who were 18 years of age and had undergone military conscription in Sweden from 1969 to 1970. Diagnostic OA codes were obtained from the Swedish National Patient Register for persons registered from 1987 to 2010. The original Nottingham model included as predictors age, sex, body mass index (BMI), knee injury, occupational risk, and family history of OA, with a receiver operating characteristic area under the curve (AUC) of 0.70 (95% confidence interval [95% CI] 0.61-0.79) in the model development sample, and AUC 0.60 (95% CI 0.58-0.63) in an external validation sample. In our sample, we used predictors that were available only in adolescence (age, BMI, and knee injury) and evaluated the discrimination of the simplified model using AUC. The AUC statistic of the modified knee OA model to predict 40-year risk was 0.60 (95% CI 0.59-0.61). Hence, using the reduced model, an 18-year-old man with a BMI of 30 and a knee injury would have 3 times the risk of developing knee OA within 40 years when compared to a man of similar age having a BMI of 25 and no knee injury (predicted risks 22% and 7%, respectively). The 40-year risk of knee OA on individual and population levels can be predicted in 18-year-olds from a few easily measured covariates with moderate discrimination. The discrimination of this simplified model based on data available in adolescents was comparable to that of the full Nottingham model in middle-aged individuals.

Identifiants

pubmed: 29953751
doi: 10.1002/acr.23685
doi:

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

558-562

Subventions

Organisme : Swedish Research Council
ID : E0234801
Pays : International
Organisme : Swedish Rheumatism Association
Pays : International
Organisme : Österlund Foundation
Pays : International
Organisme : Greta and Johan Kock Foundations
Pays : International

Informations de copyright

© 2018, American College of Rheumatology.

Auteurs

Karin Magnusson (K)

Lund University, Lund, Sweden, and Diakonhjemmet Hospital, Oslo, Norway.

Aleksandra Turkiewicz (A)

Lund University, Lund, Sweden.

Simon Timpka (S)

Lund University, Malmö, Sweden.

Martin Englund (M)

Lund University, Lund, Sweden, and Boston University School of Medicine, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH